Literature DB >> 7633105

MR imaging of myositis ossificans: variable patterns at different stages.

A Shirkhoda1, A R Armin, K G Bis, J Makris, R B Irwin, A N Shetty.   

Abstract

Five patients with a palpable mass at presentation underwent magnetic resonance (MR) imaging. The final diagnosis was myositis ossificans (MO). MR imaging features, particularly after injection of gadopentetate dimeglumine, mimicked those of an inflammatory mass or neoplasm. The lesions were excised in three patients, and the images were correlated with histologic findings. Three different appearances were noted on MR images, corresponding to the stages of maturation of MO. Two cases involved early-stage lesions, and T1-weighted MR images showed a mass with homogeneous intermediate signal intensity. Both lesions showed rim enhancement after contrast agent injection and high signal intensity on T2-weighted images. Pathologic specimens demonstrated stroma with masses of spindle cells in which osteoid production was interspersed. The enhanced rim of the lesion mimicked the expected MR appearance of an abscess or necrotic tumor. Areas of enhancement in adjacent muscle were also seen on postcontrast T1-weighted images. Intermediate-stage MO was present in one case; there was evidence of a thin rim of calcification on plain radiographs and fatty changes in the lesion on T1-weighted images, corresponding with histologic findings. One case of a mature lesion showed a considerable degree of peripheral calcification both on MR images and at histology. MR imaging is nonspecific in the diagnosis of early-stage MO.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633105     DOI: 10.1002/jmri.1880050312

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  24 in total

Review 1.  Intramuscular granular cell tumor: emphasizing the stripe sign.

Authors:  Eun Sil Kim; Seun Ah Lee; Baek Hyun Kim; Chul Hwan Kim
Journal:  Skeletal Radiol       Date:  2015-09-10       Impact factor: 2.199

2.  Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection.

Authors:  P Marzola; E Nicolato; E Di Modugno; P Cristofori; A Lanzoni; C H Ladel; A Sbarbati
Journal:  MAGMA       Date:  1999-10       Impact factor: 2.310

Review 3.  Post-traumatic ectopic calcification in the muscles of athletes: a review.

Authors:  J B King
Journal:  Br J Sports Med       Date:  1998-12       Impact factor: 13.800

4.  Severe myositis ossificans in a paraplegic trauma patient: Influence in pressure sore management.

Authors:  Wendy Lynne Parker; Jacqueline C Hodge; Marie-Lucie Lessard
Journal:  Can J Plast Surg       Date:  2004

5.  Treatment of post-traumatic myositis ossificans of the anterior thigh with extracorporeal shock wave therapy.

Authors:  David Allen Torrance; Christopher Degraauw
Journal:  J Can Chiropr Assoc       Date:  2011-12

6.  Myositis ossificans of the elbow after a trigger point injection.

Authors:  Sang-Jin Shin; Sung Shik Kang
Journal:  Clin Orthop Surg       Date:  2011-02-15

7.  Magnetic resonance signal alterations in the acute onset of heterotopic ossification in patients with spinal cord injury.

Authors:  L Wick; M Berger; H Knecht; T Glücker; H P Ledermann
Journal:  Eur Radiol       Date:  2005-04-27       Impact factor: 5.315

8.  Neurogenic heterotopic ossification: epidemiology and morphology on conventional radiographs in an early neurological rehabilitation population.

Authors:  R Seipel; S Langner; T Platz; M Lippa; J P Kuehn; N Hosten
Journal:  Skeletal Radiol       Date:  2011-02-18       Impact factor: 2.199

9.  Imaging of muscle injury in the elite athlete.

Authors:  J C Lee; A W M Mitchell; J C Healy
Journal:  Br J Radiol       Date:  2012-04-11       Impact factor: 3.039

10.  Circumscribed myositis ossificans of the masseter muscle: report of a case.

Authors:  P Piombino; G Dell'Aversana Orabona; V Abbate; G Fini; G M Liberatore; E Mici; E Belli
Journal:  G Chir       Date:  2013 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.